These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
310 related articles for article (PubMed ID: 18547629)
1. Pathogenic mechanisms of B-lymphocyte dysfunction in HIV disease. Moir S; Fauci AS J Allergy Clin Immunol; 2008 Jul; 122(1):12-9; quiz 20-1. PubMed ID: 18547629 [TBL] [Abstract][Full Text] [Related]
2. Impairment of B-cell functions during HIV-1 infection. Amu S; Ruffin N; Rethi B; Chiodi F AIDS; 2013 Sep; 27(15):2323-34. PubMed ID: 23595152 [TBL] [Abstract][Full Text] [Related]
3. B lymphocyte dysfunctions in HIV infection. De Milito A Curr HIV Res; 2004 Jan; 2(1):11-21. PubMed ID: 15053337 [TBL] [Abstract][Full Text] [Related]
4. Insights into B cells and HIV-specific B-cell responses in HIV-infected individuals. Moir S; Fauci AS Immunol Rev; 2013 Jul; 254(1):207-24. PubMed ID: 23772622 [TBL] [Abstract][Full Text] [Related]
5. HIV-1-infected children on HAART: immunologic features of three different levels of viral suppression. Zaccarelli-Filho CA; Ono E; Machado DM; Brunialti M; Succi RC; Salomão R; Kallás EG; de Moraes-Pinto MI Cytometry B Clin Cytom; 2007 Jan; 72(1):14-21. PubMed ID: 17041945 [TBL] [Abstract][Full Text] [Related]
6. B cells in HIV infection and disease. Moir S; Fauci AS Nat Rev Immunol; 2009 Apr; 9(4):235-45. PubMed ID: 19319142 [TBL] [Abstract][Full Text] [Related]
7. B cell activation and human immunodeficiency virus infection. V. Phenotypic and functional alterations in CD5+ and CD5- B cell subsets. Indraccolo S; Mion M; Zamarchi R; Veronesi A; Veronese ML; Panozzo M; Betterle C; Barelli A; Borri A; Amadori A J Clin Immunol; 1993 Nov; 13(6):381-8. PubMed ID: 7507125 [TBL] [Abstract][Full Text] [Related]
8. Antigen-dependent and -independent mechanisms of T and B cell hyperactivation during chronic HIV-1 infection. Haas A; Zimmermann K; Oxenius A J Virol; 2011 Dec; 85(23):12102-13. PubMed ID: 21849433 [TBL] [Abstract][Full Text] [Related]
9. Primary HIV-1 infection sets the stage for important B lymphocyte dysfunctions. Titanji K; Chiodi F; Bellocco R; Schepis D; Osorio L; Tassandin C; Tambussi G; Grutzmeier S; Lopalco L; De Milito A AIDS; 2005 Nov; 19(17):1947-55. PubMed ID: 16260900 [TBL] [Abstract][Full Text] [Related]
11. Suboptimal immune reconstitution in vertically HIV infected children: a view on how HIV replication and timing of HAART initiation can impact on T and B-cell compartment. Cotugno N; Douagi I; Rossi P; Palma P Clin Dev Immunol; 2012; 2012():805151. PubMed ID: 22550537 [TBL] [Abstract][Full Text] [Related]
12. Concerted effect of lymphopenia, viraemia and T-cell activation on Fas expression of peripheral B cells in HIV-1-infected patients. Rethi B; Sammicheli S; Amu S; Pensieroso S; Hejdeman B; Schepis D; Thang PH; Chiodi F AIDS; 2013 Jan; 27(2):155-62. PubMed ID: 23238551 [TBL] [Abstract][Full Text] [Related]
13. A Longitudinal Analysis Reveals Early Activation and Late Alterations in B Cells During Primary HIV Infection in Mozambican Adults. Jiménez M; Pastor L; Urrea V; Rodríguez de la Concepción ML; Parker E; Fuente-Soro L; Jairoce C; Mandomando I; Carrillo J; Naniche D; Blanco J Front Immunol; 2020; 11():614319. PubMed ID: 33519823 [TBL] [Abstract][Full Text] [Related]
14. Loss of memory (CD27) B lymphocytes in HIV-1 infection. De Milito A; Mörch C; Sönnerborg A; Chiodi F AIDS; 2001 May; 15(8):957-64. PubMed ID: 11399977 [TBL] [Abstract][Full Text] [Related]
15. Virus-specific antibody production and polyclonal B-cell activation in the intestinal mucosa of HIV-infected individuals. Eriksson K; Kilander A; Hagberg L; Norkrans G; Holmgren J; Czerkinsky C AIDS; 1995 Jul; 9(7):695-700. PubMed ID: 7546413 [TBL] [Abstract][Full Text] [Related]
16. Effective B cell activation in vitro during viremic HIV-1 infection with surrogate T cell stimulation. Nicholson LK; Pratap H; Bowers E; Gunzburger E; Bandi SR; Gardner EM; Palmer BE; Wright T; Kittelson J; Janoff EN Immunobiology; 2018 Dec; 223(12):839-849. PubMed ID: 30219203 [TBL] [Abstract][Full Text] [Related]
17. Phenotypic, functional, and kinetic parameters associated with apparent T-cell control of human immunodeficiency virus replication in individuals with and without antiretroviral treatment. Emu B; Sinclair E; Favre D; Moretto WJ; Hsue P; Hoh R; Martin JN; Nixon DF; McCune JM; Deeks SG J Virol; 2005 Nov; 79(22):14169-78. PubMed ID: 16254352 [TBL] [Abstract][Full Text] [Related]
18. Viral superantigen-induced hyporesponsiveness of T cells and polyclonal B cell activation in HIV-1 infection. Scott-Algara D; Lafon M; Vuillier F; Pialoux G; Dauguet C; Dighiero G Eur J Immunol; 1994 Nov; 24(11):2595-601. PubMed ID: 7957553 [TBL] [Abstract][Full Text] [Related]
19. CD72/CD100 and PD-1/PD-L1 markers are increased on T and B cells in HIV-1+ viremic individuals, and CD72/CD100 axis is correlated with T-cell exhaustion. Correa-Rocha R; Lopez-Abente J; Gutierrez C; Pérez-Fernández VA; Prieto-Sánchez A; Moreno-Guillen S; Muñoz-Fernández MÁ; Pion M PLoS One; 2018; 13(8):e0203419. PubMed ID: 30161254 [TBL] [Abstract][Full Text] [Related]
20. Productive infection of normal CD40-activated human B lymphocytes by HIV-1. Poulin L; Paquette N; Moir S; Lapointe R; Darveau A AIDS; 1994 Nov; 8(11):1539-44. PubMed ID: 7531456 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]